ProQR Therapeutics N.V.
PRQR- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001612940
In the last 90 days, ProQR Therapeutics N.V. insiders filed 4 open-market purchases and 0 sales; 70 institutions reported holding it in 13F filings for Q2 2026, worth $113.0M in total; no superinvestor holds it.
13F holders, Q3 2024
Institutional positions in ProQR Therapeutics N.V. as of Sep 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 47
- 0 vs. Q2 2024
- Shares held
- 17.4M
- +157.2K (+0.9%) vs. Q2 2024
- Total value
- $31.7M
- +$3.10M (+10.8%) vs. Q2 2024
- New holders
- 5
- 9 more added
- Sold out
- 5
- 15 more reduced
1 institution that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting PRQR on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 70 | $113.0M |
| Q1 2026 | 69 | $56.8M |
| Q4 2025 | 65 | $75.1M |
| Q3 2025 | 64 | $80.0M |
| Q2 2025 | 62 | $82.4M |
| Q1 2025 | 65 | $54.9M |
| Q4 2024 | 77 | $117.7M |
| Q3 2024 | 47 | $31.7M |
| Q2 2024 | 48 | $28.6M |
| Q1 2024 | 49 | $39.8M |
| Q4 2023 | 47 | $37.0M |
| Q3 2023 | 46 | $24.3M |
| Q2 2023 | 51 | $34.2M |
| Q1 2023 | 55 | $47.5M |
| Q4 2022 | 46 | $60.0M |
| Q3 2022 | 47 | $15.9M |
| Q2 2022 | 51 | $17.2M |
| Q1 2022 | 58 | $28.7M |
| Q4 2021 | 74 | $364.8M |
| Q3 2021 | 67 | $333.4M |
| Q2 2021 | 63 | $259.4M |
| Q1 2021 | 64 | $286.4M |
Institutions, Q3 2024
Shares, value and share of portfolio for each institution holding ProQR Therapeutics N.V.; share changes are against Q2 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Royal Bank of Canada | 200 | $0 | 0.00% | −855−81.0% | Reduced |
| Lazard Asset Management LLC | 103 | $0 | 0.00% | −173−62.7% | Reduced |
| TD Waterhouse Canada Inc. | 40 | $70 | 0.00% | +40 | New |
| JPMorgan Chase & Co | 300 | $546 | 0.00% | −14−4.5% | Reduced |
| PFS Partners, LLC | 1,000 | $1.82K | 0.00% | 00.0% | Unchanged |
| Flaharty Asset Management, LLC | 2,000 | $3.64K | 0.00% | +2,000 | New |
| UBS Group AG | 2,900 | $5.28K | 0.00% | −24,646−89.5% | Reduced |
| BlackRock, Inc. | 3,945 | $7.18K | 0.00% | +3,945 | New |
| Advisor Group Holdings, Inc. | 7,250 | $13.2K | 0.00% | −5,000−40.8% | Reduced |
| Federation des caisses Desjardins du Quebec | 7,496 | $13.6K | 0.00% | +7,496 | New |
| Wells Fargo & Company | 9,226 | $16.8K | 0.00% | −1,770−16.1% | Reduced |
| Truist Financial Corp | 10,000 | $18.2K | 0.00% | 00.0% | Unchanged |
| Kestra Advisory Services, LLC | 10,000 | $18.2K | 0.00% | 00.0% | Unchanged |
| Csenge Advisory Group | 10,000 | $18.5K | 0.00% | 00.0% | Unchanged |
| EP Wealth Advisors, LLC | 11,500 | $20.9K | 0.00% | 00.0% | Unchanged |
| Atom Investors LP | 13,107 | $23.9K | 0.00% | 00.0% | Unchanged |
| Prudential Financial Inc | 13,200 | $24.0K | 0.00% | +13,200 | New |
| Northern Trust Corp | 15,750 | $28.7K | 0.00% | −182−1.1% | Reduced |
| Mariner, LLC | 18,334 | $33.5K | 0.00% | 00.0% | Unchanged |
| JustInvest LLC | 21,429 | $39.0K | 0.00% | 00.0% | Unchanged |
| Bank of Montreal | 30,000 | $54.9K | 0.00% | 00.0% | Unchanged |
| RFG Advisory, LLC | 42,000 | $76.4K | 0.00% | +10,000+31.3% | Added |
| Susquehanna International Group, LLP | 42,223 | $76.8K | 0.00% | −53,895−56.1% | Reduced |
| Geode Capital Management, LLC | 46,671 | $84.9K | 0.00% | 00.0% | Unchanged |
| Resources Investment Advisors, LLC. | 57,550 | $104.7K | 0.00% | +15,550+37.0% | Added |
| BNP Paribas Arbitrage, SA | 58,801 | $107.0K | 0.00% | +7,300+14.2% | Added |
| Two Sigma Investments, LP | 62,520 | $113.8K | 0.00% | −6,425−9.3% | Reduced |
| Squarepoint Ops LLC | 71,491 | $130.1K | 0.00% | −13,242−15.6% | Reduced |
| Bank of America Corp | 73,163 | $133.2K | 0.00% | 00.0% | Unchanged |
| Citadel Advisors LLC | 86,977 | $158.3K | 0.00% | +68,612+373.6% | Added |
| Two Sigma Advisers, LP | 87,500 | $159.3K | 0.00% | −44,000−33.5% | Reduced |
| Acadian Asset Management LLC | 93,358 | $165.0K | 0.00% | +89,425+2,273.7% | Added |
| Boothbay Fund Management, LLC | 106,703 | $194.2K | 0.01% | 00.0% | Unchanged |
| Deutsche Bank AG | 108,762 | $197.9K | 0.00% | −276,387−71.8% | Reduced |
| Millennium Management LLC | 143,929 | $262.0K | 0.00% | −4,428−3.0% | Reduced |
| Franklin Street Advisors Inc | 150,000 | $273.0K | 0.02% | 00.0% | Unchanged |
| Morgan Stanley | 274,450 | $499.5K | 0.00% | +196,508+252.1% | Added |
| Monaco Asset Management SAM | 327,892 | $596.8K | 0.25% | +15,263+4.9% | Added |
| Schonfeld Strategic Advisors LLC | 412,190 | $750.2K | 0.01% | +350,290+565.9% | Added |
| Ikarian Capital, LLC | 483,583 | $880.1K | 0.27% | 00.0% | Unchanged |
| Macquarie Group Ltd | 620,000 | $1.13M | 0.00% | 00.0% | Unchanged |
| Ghost Tree Capital, LLC | 887,700 | $1.62M | 0.55% | −12,300−1.4% | Reduced |
| DAFNA Capital Management LLC | 905,582 | $1.65M | 0.39% | 00.0% | Unchanged |
| M28 Capital Management LP | 1,019,498 | $1.86M | 2.04% | 00.0% | Unchanged |
| EcoR1 Capital, LLC | 1,835,991 | $3.34M | 0.11% | −206,780−10.1% | Reduced |
| Adage Capital Partners GP, L.L.C. | 3,625,467 | $6.60M | 0.01% | 00.0% | Unchanged |
| Privium Fund Management B.V. | 5,632,388 | $10.3M | 2.55% | +51,663+0.9% | Added |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −12,471−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −6,628−100.0% | Sold out |
| Group One Trading, L.P. | 0 | $0 | 0.00% | −4,090−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −821−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −33−100.0% | Sold out |
| BlackRock Inc. | – | – | – | – | Not filed |